Investigating better endpoints for immunotherapy trials
2010-09-09
(Press-News.org) Cancer immunotherapy calls for revised clinical endpoints that differ from those used for chemotherapy, according to an article published online September 8 in The Journal of the National Cancer Institute.
Unlike chemotherapy, which acts directly on tumors, cancer immunotherapies exert their effects on the immune system, which may delay or change response patterns, perhaps owing to the dynamics of the immune system itself. For example, initial tumor burden may increase due to lymphocytic infiltration, because of T-cell proliferation, which is followed by lymphocyte-induced tumor response. These delayed reactions and other novel patterns of anti-tumor response are not part of standard criteria from the World Health Organization (WHO), or the Response Evaluation Criteria in solid Tumors (RECIST).
To study and develop a new paradigm for immunotherapy clinical trials, Axel Hoos, M.D., of the Global Clinical Research division of Bristol-Myers Squibb, looked at design and outcomes of immunotherapy clinical trials, as part of several initiatives undertaken by the Cancer Immunotherapy Consortium of the Cancer Research Institute and partner organizations between 2004 and 2009. The resulting principles for redefining immunotherapy trial endpoints were subsequently tested by Bristol-Myers Squibb (a member of the Consortium) in its immunotherapy clinical trials. In these studies, four response patterns were detected: immediate response, durable stable disease, response after tumor burden increase, and development of new lesions. The latter two are specifically recognized with immunotherapeutic agents. The results were translated into new response criteria called the immune-related response criteria, or irRC.
Hoos writes, "The irRC are generally based on the WHO and RECIST criteria and do not require a substantial departure from standard oncology practice. The novelty of the irRC lies in the measurement of new lesions, which are included in the overall tumor burden, allowing for it to be described as a continuous variable."
Furthermore, "Considering the time of translation of immunologic responses into clinical activity, the survival of patients may not be affected until some months after treatment started compared with chemotherapy," writes Hoos, adding that the kinetics observed for survival may require new statistical approaches for planning randomized trials.
In an accompanying editorial, Donald A. Berry, M.D., of the University of Texas M.D. Anderson Center, addresses the conundrum of delayed responses often induced by immunotherapies: "Any delayed effect of therapy makes product development harder and more expensive than developing a drug that works by attacking the tumor directly."
Moreover, Berry worries about another potential problem in developing immunotherapies: "To fully investigate the potential of an immunotherapy, clinicians may have to stick with it beyond a patient's progression and thereby delay switching to potentially more effective therapy," he writes.
INFORMATION:
Contacts:
Article: Communications contact: Brian Brewer, bbrewer@cancerresearch.org
Editorial: Donald A. Berry, dberry@mdanderson.org
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-09-09
BOSTON, Mass. (September 8, 2010)‹Scientists have discovered a small
molecule that helps human cells get rid of the misfolded, disfigured
proteins implicated in Alzheimer¹s disease and other neurodegenerative
ailments. This potential drug could have applications for other conditions
as well.
Cells create and discard proteins continuously, a process that relies on a
balance between the speed with which new proteins are created and damaged
ones destroyed. Protein destruction occurs through a sophisticated system
that marks proteins for disposal by tagging them with ...
2010-09-09
LA JOLLA, CA - September 7, 2010 –A team of scientists from The Scripps Research Institute, the Genomics Institute of the Novartis Research Foundation (GNF), and the U. S. Naval Research Detachment in Peru has completed a study that could improve the efficacy of diagnosis and treatment strategies for drug-resistant malaria.
In the new study—published online on September 9, 2010 by the journal Genome Research—the scientists analyzed the genomic features of a population of malaria parasites in Peru, identifying the genetic basis for resistance to a common antibiotic.
Malaria ...
2010-09-09
GAITHERSBURG, Md. – Using a one-of-a-kind instrument designed and built at the National Institute of Standards and Technology (NIST), an international team of researchers have "unveiled" a quartet of graphene's electron states and discovered that electrons in graphene can split up into an unexpected and tantalizing set of energy levels when exposed to extremely low temperatures and extremely high magnetic fields. Published in this week's issue of Nature,* the new research raises several intriguing questions about the fundamental physics of this exciting material and reveals ...
2010-09-09
The Johns Hopkins Children's Center top pediatrician is urging a "rethink" of a new sickle cell screening program, calling it an enlightened but somewhat rushed step toward improving the health of young people who carry the sickle cell mutation.
Beginning this fall, all Division I college athletes will undergo mandatory screening for the sickle cell trait. The program, rolled out by the National Collegiate Athletic Association (NCAA), is an attempt to prevent rare but often-lethal complications triggered by intense exercise in those who carry the genetic mutation yet ...
2010-09-09
Irvine, Calif. — UC Irvine researchers have discovered that markedly depleted amounts of an omega-3 fatty acid in brain tissue samples from Alzheimer's patients may be due to the liver's inability to produce the complex fat, also contained in fish-oil supplements.
Low levels of docosahexaenoic acid, or DHA, have been associated with the chronic neurodegenerative disease affecting millions of Americans, but no cause had been identified.
In postmortem liver tissue from Alzheimer's patients, the UCI team found a defect in the organ's ability to make DHA from shorter molecules ...
2010-09-09
Ghent, 9 September 2010 – Factoring the planet's multi-trillion dollar ecosystem services into policy-making can help save cities and regional authorities money while boosting the local economy, enhancing quality of life, securing livelihoods and generating employment.
This is the finding from a major international study, launched in a report by TEEB for Local and Regional Policy Makers, being released in Belgium, Brazil, India, Japan and South Africa.
In the Framework of the Belgian Presidency of the European Union, the Flemish Ministry of Environment, Nature and ...
2010-09-09
University Park, Pa. -- Repeal of birthright citizenship for the U.S.-born children of unauthorized immigrants would expand the nation's unauthorized population by at least 5 million over the next decade, according to a new report from the Migration Policy Institute.
The report's principal author is Jennifer Van Hook, professor of sociology and demographics at Penn State and non-resident fellow at the Washington, D.C.-based institute.
"While some are discussing an end to birthright citizenship as a means to reduce illegal immigration," Van Hook said, "repeal of birthright ...
2010-09-09
CHAMPAIGN, Ill. — Armed with a decade's worth of satellite data, University of Illinois atmospheric scientists have documented some surprising trends in aerosol pollution concentration, distribution and composition over the Indian subcontinent.
In addition to environmental impact, aerosol pollution, or tiny particles suspended in the air, can be detrimental to human health by causing a range of respiratory problems. Aerosols can come from natural sources, such as dust and pollen carried on the wind, but the most hazardous aerosols are generated by human activity – soot ...
2010-09-09
PHILADELPHIA –- University of Pennsylvania biologists studying human reproduction have identified what is likely the major contributing factor to the maternal age-associated increase in aneuploidy, the term for an abnormal number of chromosomes during reproductive cell division.
Using naturally aging mouse models, researchers showed that this basic fact of reproductive life is most likely caused by weakened chromosome cohesion. Older oocytes, or egg cells, have dramatically reduced amounts of a protein, REC8, that is essential for chromosomes to segregate correctly ...
2010-09-09
CHAMPAIGN, Ill. — The U.S. economy is experiencing anemic growth, yet businesses are sitting on a mountain of cash worth nearly $2 trillion, according to Federal Reserve estimates. But this trend is nothing new for firms, who have been steadily increasing their cash holdings over the past three decades, a University of Illinois business professor says.
Finance professor Heitor Almeida says the fact that businesses are stuffing corporate piggy banks with spare cash for the proverbial "rainy day" is unrelated to the belt-tightening brought about by the continuing financial ...
LAST 30 PRESS RELEASES:
[Press-News.org] Investigating better endpoints for immunotherapy trials
